SERA · Sera Prognostics, Inc.

Track SERA — free

$2.00 -0.09 (-4.31%) At close · Oct 5

Rebalance outlook locked

Market Cap

$80.48M

39.45M

Volume · Oct 5 22.91K Avg daily vol (3M) 29.22K

Up next

Next earnings call

Nov 19, 2026 Est · unconfirmed · in 6 wks

Latest filing: 10-Q

filed Aug 12, 2026

Q2 2026 earnings call transcript

call held Aug 12, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$70,000

Trailing 12 months

Net income (TTM)

−$33.23M

Trailing 12 months

Revenue growth YoY

+76.5%

Year over year

Operating margin

-53,282.9%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

-35.0%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$46.45M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+2.9%

Year over year · more shares

Price change (1Y)

-33.2%

Trailing year

Short interest

0.5%

Latest settlement · 7.6 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 15.5 · calm Equity put/call 0.59

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −8%

below

Price vs 50-day avg +2%

above

RSI (14) 53

neutral

MACD trend Positive

52-week position 23%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Weak

1-month return +6%

trailing

6-month return −2%

trailing

YTD return −29%

this year

Relative strength −14%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $2 › 200d $2 — 200d above 50d

Institutional flow Distributing

-16% holders QoQ · +1 funds added

Insider flow Distributing

Net -$63.3K over 90 days · 100% sells

Short interest Falling

0.54% of float · ▼ -3.6% MoM · 7.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

47 holders — mid 3-yr range

Squeeze score 56

elevated · 0–100

Fundamentals

Fair

Revenue growth +5%

Y/Y

EPS growth +32%

Y/Y

Free cash flow $-26.3M

Quant / Vol

risk profile

Very High

Volatility 72%

annualized · 1-yr

Max drawdown −58%

past year

ATR 4.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−8% Bearish

Price vs 50-day avg

+2% Bullish

RSI (14)

53 Neutral

MACD trend

Positive Bullish

52-week position

23% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $2 › 200d $2 — 200d above 50d

Institutional flow Distributing

-16% holders QoQ · +1 funds added

Insider flow Distributing

Net -$63.3K over 90 days · 100% sells

Short interest Falling

0.54% of float · ▼ -3.6% MoM · 7.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

47 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $2 Now $2 · 23% Range high $4

vs 200-day avg -8% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
cash, cash equivalents and available-for-sale securities	$80.3M	Q2 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
SERA Sera Prognostics, Inc. this stock	$80.48M	-29.2%	+5.2%	—	0.5%
ABT Abbott Laboratories	$174.90B	-22.2%	+5.7%	28.1	1.1%
MDT Medtronic plc	$113.38B	-10.1%	+8.4%	21.8	1.3%
SYK Stryker Corp	$104.47B	-21.6%	+11.2%	28.2	2.0%
BSX Boston Scientific Corp	$63.59B	-55.3%	+12.5%	17.8	3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

% held: 43.2%
Net QoQ: -2.9M sh
Top holder: BAKER BROS. ADVISORS LP

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

213.9K

Days to cover: 7.6d
Change: -7.9K sh

View

Short Volume

Short vol %

41%

As of: Oct 5, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $6
As of: Sep 14, 2026

View

Off-Exchange

Off-exchange %

48.1%

Week of: Aug 31, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$63.3K

Buyers / Sellers: 0 / 4

Buyers Sellers

View

Financials

Revenue (FY)

$81.0K

Net income (FY): $-31.9M
EPS diluted: $-0.67

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 19, 2026
This year: 14

View

Proposed Sales

Value

$4.4K

Shares: 2.2K
Filed: Sep 11, 2026

View

Exempt Offerings

Offering

$100.3M

Filed: May 11, 2021

View

Earnings & Events

Webcasts

Last webcast

Aug 12, 2026

View

Performance

	5D	20D	120D	MTD	YTD
SERA	+2.5%	+5.6%	-1.9%	+0.0%	-29.2%
SPY	-0.2%	-0.5%	+12.2%	+0.9%	+12.9%
vs SPY	+2.7%	+6.0%	-14.1%	-0.9%	-42.0%

Key facts CIK 1534969 CUSIP 81749D107 13F (30d) 2 filings 2 filers Visit website Investor relations

SERA · Sera Prognostics, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance